Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMO | Q99835 | 13/20 | 0.67 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.46 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL15938613 | 0.99 | SMO (0.66) | SMOMAPK14LMNAHTTSMN1; SMN2 | |
| SCHEMBL14810218 | 0.96 | SMO (0.65) | SMOMAPK14LMNAHTTSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL15938876 | 0.96 | SMO (0.64) | SMOMAPK14LMNAHTTSMN1; SMN2 | |
| SCHEMBL14809786 | 0.94 | SMO (0.67) | SMOMAPK14MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL15939026 | 0.94 | SMO (0.66) | SMOMAPK14MEN1KMT2A | |
| SCHEMBL15944124 | 0.92 | SMO (0.56) | SMOMAPK14HTTSMN1; SMN2MEN1 | |
| SCHEMBL8296454 | 0.92 | SMO (0.72) | SMOMAPK14MEN1KMT2A | |
| SCHEMBL8225752 | 0.90 | SMO (0.82) | SMOMAPK14 | |
| SCHEMBL14809743 | 0.90 | SMO (0.70) | SMOMAPK14MEN1KMT2A | |
| SCHEMBL14810121 | 0.90 | SMO (0.63) | SMOMAPK14SMN1; SMN2TDP1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2758369-B1 | NOVEL COMPOUNDS MODULATING THE HEDGEHOG PROTEIN SIGNALING PATHWAY, MARKED FORMS THEREOF, AND APPLICATIONS | CENTRE NAT RECH SCIENT (FR) | 2016-03-23 | — | — | EP | claimed |
| US-8981149-B2 | Compounds modulating the hedgehog protein signaling pathway, marked forms thereof, and applications | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2015-03-17 | — | — | US | claimed |
| US-20140228441-A1 | Novel Compounds Modulating The Hedgehog Protein Signaling Pathway, Marked Forms Thereof, And Applications | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2014-08-14 | — | — | US | claimed |
| EP-2758369-B1 | NOVEL COMPOUNDS MODULATING THE HEDGEHOG PROTEIN SIGNALING PATHWAY, MARKED FORMS THEREOF, AND APPLICATIONS | CENTRE NAT RECH SCIENT (FR) | 2016-03-23 | — | — | EP | disclosed |
| EP-2758369-B1 | NOVEL COMPOUNDS MODULATING THE HEDGEHOG PROTEIN SIGNALING PATHWAY, MARKED FORMS THEREOF, AND APPLICATIONS | CENTRE NAT RECH SCIENT (FR) | 2016-03-23 | — | — | EP | disclosed |
| US-8981149-B2 | Compounds modulating the hedgehog protein signaling pathway, marked forms thereof, and applications | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2015-03-17 | — | — | US | disclosed |
| US-20140228441-A1 | Novel Compounds Modulating The Hedgehog Protein Signaling Pathway, Marked Forms Thereof, And Applications | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2014-08-14 | — | — | US | disclosed |
| EP-2758369-A1 | NOVEL COMPOUNDS MODULATING THE HEDGEHOG PROTEIN SIGNALING PATHWAY, MARKED FORMS THEREOF, AND APPLICATIONS | Centre National De La Recherche Scientifique (FR) | 2014-07-30 | — | — | EP | disclosed |
| WO-2013042082-A1 | NOVEL COMPOUNDS MODULATING THE HEDGEHOG PROTEIN SIGNALING PATHWAY, MARKED FORMS THEREOF, AND APPLICATIONS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2013-03-28 | — | — | WO | disclosed |
| WO-2013042082-A1 | NOVEL COMPOUNDS MODULATING THE HEDGEHOG PROTEIN SIGNALING PATHWAY, MARKED FORMS THEREOF, AND APPLICATIONS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2013-03-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140228441-A1 | Novel Compounds Modulating The Hedgehog Protein Signaling Pathway, Marked Forms Thereof, And Applications | SMO, SHH, GLI1 | SMO 1/4885MAPK14 1707/4885LMNA 4339/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.